IFNG and neoplasm: Recently, a randomized, placebo-controlled trial revealed a trained immunity program characterized by modulation of γδ T cell function, with higher production of TNF and IFN-γ, as well as upregulation of cellular metabolic pathways, induced by the measles, mumps, and rubella (MMR) vaccination, providing new idea for the future development of tumor vaccines (54).